Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Honghua dripping pill for stable exertional angina (phase II)
CTR20132948Phase 2Completed
- Sponsor
- Shanxi Deyuantang Pharmaceutical
- Start
- Jul 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Honghua dripping pill in coronary arteriosclerosis, stable angina, sponsored by Shanxi Deyuantang Pharmaceutical. Started Jul 2014; status: completed.
02
Drugs
Honghua dripping pill
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on CTR20132948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132948.